Literature DB >> 1980921

The HLA-DR beta 16 allogenotype constitutes a risk factor for hypertrophic scarring.

C Castagnoli1, D Peruccio, M Stella, G Magliacani, G Mazzola, A Amoroso, P Richiardi.   

Abstract

Nineteen patients that had developed hypertrophic scars subsequent to thermal injury were typed for HLA class II allogenotypes with the restriction fragment length polymorphism technique. A significant association was found with DR beta 16 (pc = 1.45 x 10(-4); relative risk = 12.25). This finding adds evidence to other data suggesting that immunologic phenomena are involved in pathologic scarring. Moreover, the results presented here have allowed an identification of a genetically determined risk factor for hypertrophic scar formation located in the HLA region.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1980921     DOI: 10.1016/0198-8859(90)90117-8

Source DB:  PubMed          Journal:  Hum Immunol        ISSN: 0198-8859            Impact factor:   2.850


  3 in total

Review 1.  Prevention and treatment of excessive dermal scarring.

Authors:  Ingrid E Roseborough; Mark A Grevious; Raphael C Lee
Journal:  J Natl Med Assoc       Date:  2004-01       Impact factor: 1.798

2.  Missense Variant in MAPK Inactivator PTPN5 Is Associated with Decreased Severity of Post-Burn Hypertrophic Scarring.

Authors:  Ravi F Sood; Saman Arbabi; Shari Honari; Nicole S Gibran
Journal:  PLoS One       Date:  2016-02-12       Impact factor: 3.240

3.  A Preliminary Report of the Biochemical and Clinical Effects of 1,4-Diaminobutane on Prevention of Human Hypertrophic Scars.

Authors:  Kenneth N Dolynchuk; Edward E Tredget
Journal:  Plast Reconstr Surg       Date:  2020-01       Impact factor: 5.169

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.